Evidence map›Paper›PMID 39350752›Full record

ArticleDisease models & mechanisms2024

A Drosophila model for mechanistic investigation of tau protein spread.

Kondalarao Bankapalli, Ruth E Thomas, Evelyn S Vincow, Gillian Milstein, Laura V Fisher, Leo J Pallanck

Abstract read
In one paragraph

Article in Disease models & mechanisms, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Brain communications · 2024
    Article
4 · The record

Corrections and comments

  • Update of
    A2024
5 · Who and what money

Authors and funding

6 authors.

Kondalarao BankapalliDepartment of Genome Sciences, University of Washington, 3720 15th Avenue NE, Seattle, WA98195, USA.
Ruth E ThomasDepartment of Genome Sciences, University of Washington, 3720 15th Avenue NE, Seattle, WA98195, USA.
Evelyn S VincowDepartment of Genome Sciences, University of Washington, 3720 15th Avenue NE, Seattle, WA98195, USA.
Gillian MilsteinDepartment of Genome Sciences, University of Washington, 3720 15th Avenue NE, Seattle, WA98195, USA.
Laura V FisherDepartment of Genome Sciences, University of Washington, 3720 15th Avenue NE, Seattle, WA98195, USA.
Leo J PallanckDepartment of Genome Sciences, University of Washington, 3720 15th Avenue NE, Seattle, WA98195, USA.ORCID 0000-0002-5943-9339

Funding

Mechanism of innate immune activation in a Drosophila model of Alzheimer's disease related dementiaR01AG075100 · NIA · UNIVERSITY OF WASHINGTON · PI Leo J Pallanck · 2022 to 2026
$1.9M
Drosophila models to study Prion-like propagation of the protein aggregates that characterize Alzheimer's and Parkinson's diseaseR21AG070374 · NIA · UNIVERSITY OF WASHINGTON · PI PALLANCK, LEO J · 2020 to 2020
$428k
NIA NIH HHS R01 AG075100NIA NIH HHS R21 AG070374NIH HHS R21AG070374University of Washington
6 · The paper itself

Abstract

Brain protein aggregates are a hallmark of neurodegenerative disease. Previous work indicates that specific protein components of these aggregates are toxic, including tau (encoded by MAPT) in Alzheimer's disease and related tauopathies. Increasing evidence also indicates that these toxic proteins traffic between cells in a prion-like fashion, thereby spreading pathology from one brain region to another. However, the mechanisms involved in trafficking are poorly understood. We therefore developed a transgenic Drosophila model to facilitate rapid evaluation of candidate tau trafficking modifiers. Our model uses the bipartite Q system to drive co-expression of tau and GFP in the fly eye. We found age-dependent spread of tau into the brain, represented by detection of tau, but not of GFP. We also found that tau trafficking was attenuated upon inhibition of the endocytic factor dynamin (encoded by shi) or knockdown of glycogen synthase kinase-3β (GSK-3β, encoded by sgg). Further work revealed that dynamin promoted tau uptake in recipient tissues, whereas GSK-3β appeared to promote tau spread via direct phosphorylation of tau. Our robust and flexible system will promote the identification of tau-trafficking components involved in the pathogenesis of neurodegenerative diseases.

Indexed as

Animals, Genetically ModifiedDisease Models, AnimalDrosophila melanogasterDrosophila ProteinsGlycogen Synthase Kinase 3 betatau ProteinsAnimalsBrainDynaminsGlycogen Synthase Kinase 3Green Fluorescent ProteinsHumansPhosphorylationProtein TransportDrosophila ProteinsDynaminsGlycogen Synthase Kinase 3Glycogen Synthase Kinase 3 betaGreen Fluorescent ProteinsSgg protein, Drosophilatau ProteinsDrosophilaNeurodegenerationPrionSpreadTauα-synuclein

Identifiers

PMID39350752
PMCPMC11463956

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.